We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
NAMP
576
NorthStar Asset Management (Pennsylvania)
Pennsylvania
$11.2M +$5.33K +10 +0%
AWM
577
Axxcess Wealth Management
California
$11M +$3.96M +7,427 +52%
ECM
578
Element Capital Management
New York
$11M -$16.1M -30,290 -58%
FNBT
579
FineMark National Bank & Trust
Florida
$10.9M +$8.61M +16,160 +296%
ATC
580
Argent Trust Co
Tennessee
$10.9M +$105K +197 +0.9%
Lido Advisors
581
Lido Advisors
California
$10.9M +$255K +479 +2%
Westfield Capital Management
582
Westfield Capital Management
Massachusetts
$10.9M -$14.5M -27,132 -56%
BCM
583
Bancreek Capital Management
California
$10.9M +$2.76M +5,172 +32%
BS
584
Banco Santander
Spain
$10.8M +$3.12M +5,857 +38%
QCM
585
Quantinno Capital Management
New York
$10.8M +$3.08M +5,779 +37%
Wealthfront Advisers
586
Wealthfront Advisers
California
$10.7M +$435K +817 +4%
NCM
587
Novare Capital Management
North Carolina
$10.7M +$383K +719 +4%
MFWM
588
Motley Fool Wealth Management
Virginia
$10.7M -$262K -491 -2%
PAG
589
Private Advisor Group
New Jersey
$10.6M -$1.38M -2,583 -11%
AC
590
Armistice Capital
New York
$10.6M -$12.8M -24,000 -53%
WB
591
Webster Bank
Connecticut
$10.6M -$246K -461 -2%
AAM
592
Advisors Asset Management
Colorado
$10.6M -$82.6K -155 -0.7%
JCM
593
Janney Capital Management
Pennsylvania
$10.6M -$46.4K -87 -0.4%
WP
594
Waycross Partners
Kentucky
$10.5M +$566K +1,063 +5%
PM
595
Phraction Management
Connecticut
$10.5M +$1.11M +2,089 +11%
MCM
596
McRae Capital Management
New Jersey
$10.5M +$4.62M +8,675 +72%
SIC
597
Salem Investment Counselors
North Carolina
$10.4M +$1.18M +2,215 +12%
GD
598
Grandfield & Dodd
New York
$10.4M -$137K -258 -1%
RSS
599
Rosenblum Silverman Sutton
California
$10.2M -$46.9K -88 -0.4%
Empower Advisory Group
600
Empower Advisory Group
Colorado
$10.2M +$8.87M +16,648 +467%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.